Isaac Health GUIDE model has launched – click here to book

 

The best care for every brain®

Press releases

digital health new york 100

Isaac Health Named to the 2025 New York Digital Health 100 by Digital Health New York (DHNY)

DH100 recognizes those companies that have helped make New York the capital of healthcare innovation New York, NY (February 6, 2025) – Isaac Health, a leading national provider of brain health and dementia care, is proud to announce that it has been named to the 2025 New York Digital Health 100 (DH100), a recognition that …

Isaac Health Named to the 2025 New York Digital Health 100 by Digital Health New York (DHNY) Read More »

Isaac Health Awarded National Telehealth Accreditation from The Joint Commission

New York, NY, December 4, 2024 – Isaac Health has earned The Joint Commission’s Gold Seal of Approval® for Telehealth Accreditation by demonstrating continuous compliance with its performance standards. The Gold Seal is a symbol of quality that reflects a health care organization’s commitment to providing safe and quality patient care at the highest standards.  …

Isaac Health Awarded National Telehealth Accreditation from The Joint Commission Read More »

Isaac Health and Pearl Health Partner to Streamline Dementia Care through the CMS GUIDE Model

July 19, 2024 – Isaac Health, a leading national provider of brain health and dementia care, and Pearl Health, a leading technology company focused on physician enablement in value-based care, are excited to announce a strategic partnership to deliver the CMS Guiding an Improved Dementia Experience (GUIDE) Model to Traditional Medicare beneficiaries aligned with Pearl’s …

Isaac Health and Pearl Health Partner to Streamline Dementia Care through the CMS GUIDE Model Read More »

Kisunla

FDA Approval of Donanemab Marks Major Advance in Alzheimer’s Treatment

July 2, 2024 – The U.S. Food and Drug Administration (FDA) has approved donanemab, a groundbreaking treatment for Alzheimer’s disease. Branded as Kisunla™ (pronounced kih-SUHN-lah) by Eli Lilly, donanemab is an amyloid plaque-targeting therapy for persons living with mild cognitive impairment (MCI) or in the mild dementia stage of Alzheimer’s disease with confirmed amyloid pathology. …

FDA Approval of Donanemab Marks Major Advance in Alzheimer’s Treatment Read More »

Isaac Health Joins CMS GUIDE Model Program to Enhance Dementia Care Nationwide

NEW YORK, New York, July 1, 2024 – Isaac Health, a leading national telehealth provider of brain health and dementia care, is a participant in the Centers for Medicare & Medicaid Services’ (CMS) Guiding an Improved Dementia Experience (GUIDE) Model, launching today. This program enables Isaac Health to deliver comprehensive, personalized care to individuals living …

Isaac Health Joins CMS GUIDE Model Program to Enhance Dementia Care Nationwide Read More »

CaringKind and Isaac Health Partner to Deliver Comprehensive Dementia Care through the GUIDE Model

NEW YORK, April 17, 2024 – Isaac Health, a leading national provider of brain health and dementia care, is thrilled to expand their existing relationship with New York-headquartered CaringKind to offer individuals and families affected by dementia new support provided through the Centers for Medicare & Medicaid Services’ (CMS) Guiding an Improved Dementia Experience (GUIDE) …

CaringKind and Isaac Health Partner to Deliver Comprehensive Dementia Care through the GUIDE Model Read More »

Isaac Health is an accepted participant in CMS GUIDE Model Program

NEW YORK, New York, April 9, 2024 – Isaac Health, a leading national provider of brain health and dementia care, has been accepted in the established and new model tracks of the ​​Centers for Medicare & Medicaid Services’ (CMS) Guiding an Improved Dementia Experience (GUIDE) Model.  The GUIDE Model focuses on enhancing care for individuals …

Isaac Health is an accepted participant in CMS GUIDE Model Program Read More »

CMS Innovation

CMS Launches New Dementia Care Management Program

The Centers for Medicare & Medicaid Services (CMS) has launched a new dementia care management program called GUIDE (Guiding an Improved Dementia Experience). This program is designed to improve the quality of care and support for people living with dementia and their caregivers. Isaac Health is a proud participant in the GUIDE Model right from …

CMS Launches New Dementia Care Management Program Read More »

Utilization management

White Paper on cost implications of Leqembi and other anti-amyloid drugs for payers and ACOs and options for utilization management

Introduction: The recent full approval of Lecanemab (Leqembi) by the FDA has ushered in a new era in the treatment of Alzheimer’s disease. As the first disease-modifying treatment to receive such approval, Leqembi offers hope to patients with early-stage Alzheimer’s. However, its adoption poses cost implications for payers and risk-bearing health systems. In a newly …

White Paper on cost implications of Leqembi and other anti-amyloid drugs for payers and ACOs and options for utilization management Read More »

Request patient flyers